ELOVL2 抗体 (AA 247-296)
Our Local Distributor
北京 101111
Quick Overview for ELOVL2 抗体 (AA 247-296) (ABIN7266927)
抗原
See all ELOVL2 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 247-296
-
原理
- ELOVL2 Rabbit pAb
-
序列
- ILFLNFYVQT YRKKPMKKDM QEPPAGKEVK NGFSKAYFTA ANGVMNKKAQ
-
交叉反应
- 人, 大鼠
-
产品特性
- Polyclonal Antibodies
-
纯化方法
- Affinity purification
-
免疫原
- Recombinant fusion protein containing a sequence corresponding to amino acids 247-296 of human ELOVL2 (NP_060240.3).
-
亚型
- IgG
-
-
-
-
应用备注
- WB,1:500 - 1:2000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- ELOVL2 (ELOVL Fatty Acid Elongase 2 (ELOVL2))
-
别名
- ELOVL2
-
背景
- Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs per cycle. Condensing enzyme that catalyzes the synthesis of polyunsaturated very long chain fatty acid (C20- and C22-PUFA, acting specifically toward polyunsaturated acyl-CoA with the higher activity toward C20:4(n-6 acyl-CoA. May participate in the production of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators.,SSC2,ELOVL2,Cancer,Signal Transduction,Endocrine & Metabolism,Lipid Metabolism,Endocrine and metabolic diseases,Diabetes,Cardiovascular,Heart,Lipids,Fatty Acids,Cardiovascular diseases,Heart disease,ELOVL2
-
基因ID
- 54898
-
UniProt
- Q9NXB9
抗原
-